Search trials for
Showing NN of NN trials
Enrolling

Savolitinib vs. Sunitinib in MET-driven PRCC

This study is designed for patients diagnosed with MET-driven, unresectable and locally advanced or metastatic Papillary Renal Cell Carcinoma. The...

Enrolling

RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-Ac...

Chronic Kidney Disease (CKD) is a known risk factor of cardiovascular morbidity and mortality. In...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney...

Enrolling

Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism a...

Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Enrolling

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian HD Subjects With SHP...

To demonstrate that treatment with etelcalcetide (AMG 416) is not inferior to treatment with cinacalcet for lowering serum intact parathyroid...

Enrolling

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD...

Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI

Enrolling

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadust...

This study will be conducted to assess the pharmacokinetics of vadadustat 600, 750, and 900 milligrams daily, and intravenous erythropoiesis-stimulating...

Enrolling

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant P...

This is a Phase 2, open-label, parallel-group, multiple dose study designed to evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of...

Enrolling

Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin...

This is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmacodynamic (PK/PD) study to evaluate oral vadadustat for the treatment of...

Enrolling

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment o...

A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Enrolling

Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in...

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in subjects...

Enrolling

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by...

Efficacy and safety of LNP023 in IgAN patients

Enrolling

A Phase IIA Study of Blood Pressure Comparing Daprodustat to an Erythropoiesis-s...

This will be an open-label, randomized, parallel-group study in hemodialysis-dependent (HD) subjects with anemia associated with chronic kidney disease (CKD),...

Not Yet Enrolling

Pentoxifylline in Diabetic Kidney Disease

Pentoxifylline (PTX) is a medication that has been on the market since 1984 for use in disease in the blood...